Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,524,888
  • Shares Outstanding, K 41,938
  • Annual Sales, $ 787,310 K
  • Annual Income, $ 37,730 K
  • 60-Month Beta 1.12
  • Price/Sales 4.15
  • Price/Cash Flow 29.58
  • Price/Book 4.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.60
  • Number of Estimates 3
  • High Estimate 0.61
  • Low Estimate 0.59
  • Prior Year 0.55
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.05 +5.00%
on 01/03/20
89.15 -5.72%
on 01/17/20
+1.56 (+1.89%)
since 12/24/19
3-Month
68.78 +22.20%
on 10/31/19
89.15 -5.72%
on 01/17/20
+8.39 (+11.09%)
since 10/24/19
52-Week
62.40 +34.70%
on 01/30/19
92.59 -9.22%
on 06/21/19
+19.37 (+29.95%)
since 01/24/19

Most Recent Stories

More News
Hill-Rom (HRC) Gains Ground on Global Expansion, New Menu

Hill-Rom (HRC) is optimistic about its latest buyouts of Breathe Technologies and Voalte, mirroring its outstanding capital management strategy in turn.

OMCL : 84.05 (-2.44%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
MDT : 119.26 (-1.41%)
Here's Why You Should Retain Edwards Lifesciences Stock Now

Investors can hold on to Edwards Lifesciences (EW) in their portfolio for now, thanks to solid prospects.

OMCL : 84.05 (-2.44%)
EW : 230.45 (-0.35%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
Allegheny General Hospital Partners with Omnicell to Automate Sterile Compounding

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Allegheny General Hospital, Pittsburgh,...

OMCL : 84.05 (-2.44%)
Hologic (HOLX) Hits a 52-Week High: What's Driving the Stock?

Hologic (HOLX) gains from several positive developments.

OMCL : 84.05 (-2.44%)
HOLX : 53.72 (-0.19%)
HAE : 107.45 (-2.37%)
HRC : 109.64 (-2.81%)
Integra Announces Preliminary Q4 Results, Share Buyback Plan

Integra (IART) projects fourth-quarter 2019 revenues at or near the low end of its previously-announced guidance.

OMCL : 84.05 (-2.44%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
IART : 55.21 (-1.73%)
Here's Why You Should Add Bruker (BRKR) to Your Portfolio Now

Investor confidence in Bruker (BRKR) is at a high, thanks to solid prospects.

OMCL : 84.05 (-2.44%)
BRKR : 52.40 (-0.80%)
HAE : 107.45 (-2.37%)
WST : 155.75 (-0.51%)
5 Promising Growth Stocks in MedTech to Invest in 2020

We have zeroed in on five impressive growth stocks in MedTech on the back of the industry's lucrative prospects.

HMSY : 27.00 (-3.88%)
CERN : 74.46 (-1.61%)
OMCL : 84.05 (-2.44%)
LHCG : 146.73 (-0.63%)
WST : 155.75 (-0.51%)
Invest in These 5 Low Leverage Stocks Before Q4 Earnings

Companies displaying high earnings growth along with high leverage ratios should be avoided while making investment decisions. So, investors should select companies with low leverage.

MDU : 29.80 (-0.93%)
OMCL : 84.05 (-2.44%)
CHE : 477.73 (-0.49%)
AMED : 178.98 (-0.75%)
OMP : 16.55 (-1.55%)
Varian (VAR) Hits a 52-Week High: What's Driving the Stock?

Varian (VAR) gains from several positive developments.

OMCL : 84.05 (-2.44%)
VAR : 148.29 (-0.75%)
HAE : 107.45 (-2.37%)
WST : 155.75 (-0.51%)
Amedisys Gains on Favorable Demography, New Hospice Buyouts

Amedisys (AMED) is steadily benefiting from its recent takeovers of hospice care providers, namely RoseRock Healthcare and Compassionate Care Hospice.

OMCL : 84.05 (-2.44%)
HAE : 107.45 (-2.37%)
AMED : 178.98 (-0.75%)
WST : 155.75 (-0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Trade OMCL with:

Business Summary

Omnicell, Inc. is a leading provider of medication and supply management automation, analytics software, and medication adherence solutions for healthcare organizations. It works with healthcare providers to drive operational efficiency by removing tedious tasks and waste. Regardless of distribution...

See More

Key Turning Points

2nd Resistance Point 87.39
1st Resistance Point 85.72
Last Price 84.05
1st Support Level 83.05
2nd Support Level 82.05

See More

52-Week High 92.59
Last Price 84.05
Fibonacci 61.8% 81.06
Fibonacci 50% 77.49
Fibonacci 38.2% 73.93
52-Week Low 62.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar